DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
De Cock E, Knoop A, Jacobsen EH et al.
Manual injection of subcutaneous trastuzumab vs. intravenous infusion for HER2-positive early breast cancer: a time-and-motion study. European Cancer Congress 2013, Amsterdam, Abstr. 1965.
We do not assume any responsibility for the contents of the web pages of other providers.